Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses.
Sardar P, Beresford-Jones BS, Xia W, Shabana O, Suyama S, Ramos RJF, Soderholm AT, Tourlomousis P, Kuo P, Evans AC, Imianowski CJ, Conti AG, Wesolowski AJ, Baker NM, McCord EAL, Okkenhaug K, Whiteside SK, Roychoudhuri R, Bryant CE, Cross JR, Pedicord VA.
Sardar P, et al. Among authors: cross jr.
Nat Microbiol. 2025 Mar;10(3):795-807. doi: 10.1038/s41564-025-01930-y. Epub 2025 Feb 10.
Nat Microbiol. 2025.
PMID: 39929976
Free PMC article.